Your browser doesn't support javascript.
loading
An early look at the second dose completion of the recombinant zoster vaccine in Canadian adults: A retrospective database study.
McGirr, Ashleigh; Bourgoin, Tara; Wortzman, Michael; Millson, Brad; McNeil, Shelly A.
Affiliation
  • McGirr A; GSK, Mississauga, Canada. Electronic address: ashleigh.a.mcgirr@gsk.com.
  • Bourgoin T; IQVIA, Ottawa, Canada.
  • Wortzman M; GSK, Mississauga, Canada.
  • Millson B; IQVIA, Ottawa, Canada.
  • McNeil SA; Canadian Center for Vaccinology, IWK Health Centre and Nova Scotia Health Authority, Dalhousie University, Halifax, Canada.
Vaccine ; 39(25): 3397-3403, 2021 06 08.
Article in En | MEDLINE | ID: mdl-34001346
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Herpes Zoster Vaccine / Herpes Zoster Type of study: Observational_studies Limits: Adult / Humans / Infant Country/Region as subject: America do norte Language: En Journal: Vaccine Year: 2021 Document type: Article Country of publication: Netherlands
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Herpes Zoster Vaccine / Herpes Zoster Type of study: Observational_studies Limits: Adult / Humans / Infant Country/Region as subject: America do norte Language: En Journal: Vaccine Year: 2021 Document type: Article Country of publication: Netherlands